Company Performance: TCGN's revenue, profit margins, and earnings per share directly influence investor confidence.

Industry Trends: The overall health and growth prospects of the biotechnology sector impact TCGN's valuation.

Clinical Trial Results: Positive or negative outcomes from clinical trials of TCGN's drug candidates significantly affect stock price.

Regulatory Approvals: FDA or other regulatory body approvals for TCGN's products lead to price increases.

Market Sentiment: General investor optimism or pessimism can influence TCGN's stock price, even without specific company news.

Competition: The emergence of competing drugs or therapies can negatively affect TCGN's market share and stock price.

Partnerships and Collaborations: Strategic alliances or partnerships with other companies often boost investor confidence.

Economic Conditions: Broad economic factors like interest rates, inflation, and GDP growth can indirectly influence TCGN's valuation.

Management Changes: Significant changes in TCGN's leadership can impact investor perception and stock price.

Financial Health: TCGN's cash flow, debt levels, and ability to raise capital are crucial factors affecting its stock price.

News and Media Coverage: Positive or negative news articles and media reports can influence investor sentiment.

Analyst Ratings: Investment analysts' ratings and price targets for TCGN can influence investor decisions.

Technological Advancements: Breakthroughs in biotechnology or related fields can impact TCGN's prospects.

Intellectual Property: The strength and protection of TCGN's patents and intellectual property are vital for its value.